{"acute hepatic failure": 2.68, "ammonia increased": 5.59, "anaemia": 2.82, "ascites": 19.01, "autoimmune hepatitis": 3.85, "blood bilirubin increased": 4.9, "blood creatinine increased": 2.28, "cholangiocarcinoma": 18.77, "cryoglobulinaemia": 40.1, "drug ineffective": 13.25, "drug resistance": 4.72, "encephalopathy": 4.83, "genotype drug resistance test positive": 347.74, "glomerular filtration rate decreased": 10.8, "haemorrhagic stroke": 2.61, "hepatic cancer": 4.1, "hepatic cancer recurrent": 387.38, "hepatic cirrhosis": 21.29, "hepatic encephalopathy": 26.0, "hepatic failure": 9.04, "hepatic lesion": 6.69, "hepatic mass": 23.78, "hepatic pain": 4.94, "hepatitis b reactivation": 37.55, "hepatitis c": 362.28, "hepatitis c virus test positive": 240.77, "hepatocellular carcinoma": 99.5, "hyperbilirubinaemia": 3.32, "immune system disorder": 3.34, "incorrect product administration duration": 2.85, "intentional dose omission": 4.84, "jaundice": 2.18, "liver transplant": 31.35, "lymphoma": 2.31, "metastases to lymph nodes": 4.57, "oesophageal varices haemorrhage": 52.25, "paranoia": 2.13, "portal vein thrombosis": 8.42, "product use complaint": 4.24, "pulmonary arterial hypertension": 2.03, "renal impairment": 3.15, "septic shock": 2.27, "subarachnoid haemorrhage": 3.9, "sudden death": 3.8, "therapy cessation": 3.63, "therapy non-responder": 2.03, "treatment failure": 71.81, "treatment noncompliance": 5.31, "unevaluable event": 2.47, "upper gastrointestinal haemorrhage": 2.72, "varices oesophageal": 17.21, "viral load increased": 4.59, "viral mutation identified": 147.45, "virologic failure": 21.96}